Antibiotic-impregnated ventriculoperitoneal shunts - A multi-centre British paediatric neurosurgery group (BPNG) study using historical controls

Child's Nervous System

Volumn 27, Issue 4, 2011, Pages 575-581

  Kandasamy, Jothy ^a   Dwan, Kerry ^c   Hartley, John C ^d   Jenkinson, Michael D ^b   Hayhurst, Caroline ^a   Gatscher, Sylvia ^d   Thompson, Dominic ^d   Crimmins, Darach ^e   Mallucci, Conor ^a  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Antibiotic impregnated catheter; Hydrocephalus; Shunt infection

Indexed keywords

AMIKACIN; CEFUROXIME; CLINDAMYCIN; FLUCLOXACILLIN; RIFAMPICIN;

ADOLESCENT; ANTIBIOTIC IMPREGNATED SHUNT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM DETECTION; BRAIN VENTRICLE PERITONEUM SHUNT; CHILD; DATA BASE; GROUPS BY AGE; HUMAN; HYDROCEPHALUS; IMPLANT; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHUNT INFECTION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; GREAT BRITAIN; HUMANS; HYDROCEPHALUS; INFANT; INFANT, NEWBORN; NEUROSURGERY; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; VENTRICULOPERITONEAL SHUNT;

EID: 79953814620     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-010-1290-z     Document Type: Article

References (33)

1. Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML (2005) Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 21:56-61
2. Bayston R (1989) Hydrocephalus shunt infections. Chapman and Hall, London
3. Bayston R, Grove N, Siegel J, Lawellin D, Barsham S (1989) Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52:605-609 (Pubitemid 19151717)
4. Bayston R, Lambert E (1997) Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 87:247-251 (Pubitemid 27349109)
5. Bayston R, Ashraf W, Bhundia C (2004) Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 53:778-782 (Pubitemid 38660278)
6. Belli A, Thompson DNP, Harkness WFJ, Pitt M, Hayward RD (2001) Shunt infection rates: surgical skill or statistical serendipity? Analysis of 1,106 cases. Br J Neurosurg 15:82, Abstract
7. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE (1995) Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first time shunts. Acta Neurochir (Wien) 136:1-7
8. Choksey MS, Malik IA (2004) Zero tolerance to shunt infections: can it be achieved? J Neurol Neurosurg Psychiatry 75:87-91
9. Choux M, Genitori L, Lang D, Lena G (1992) Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 77:875-880
10. Drake JM, Sainte-Rose C (1995) The shunt book. Blackwell Science, Cambridge, Mass
11. Enger PO, Svendsen F, Wester K (2003) CSF shunt infections in children: experiences from a population-based study. Acta Neurochir (Wien) 145:243-248 (Pubitemid 36560920)
12. Eymann R, Chehab S, Strowitzki M, Steudel W-I, Keifer M (2008) Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatrics 1:444-450 (Pubitemid 351798833)
13. Fan-Havard P, Nahata MC (1987) Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm 6:866-880 (Pubitemid 17162996)
14. Govender ST, Nathoo N, van Dellen JR (2003) Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831-839 (Pubitemid 37314917)
15. Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL (2008) The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 24(5):557-562, Epub 2007 Oct 26 (Pubitemid 351566604)
16. Kan P, Kestle J (2007) Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 23:773-777 (Pubitemid 46864028)
17. Kulkarni AV, Drake JM, Lamberti-Pasculli M (2001) Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 94:195-201 (Pubitemid 32799678)
18. Pattavilakom A, Kotasnas D, Korman TM, Xenos C, Danks A (2006) Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters. Neurosurgery 58:930-935
19. Pattavilakom A, Xenos C, Bradfield O, Danks RA (2007) Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci 14(6):526-531 (Pubitemid 46550900)
20. Pople IK, Bayston R, Hayward RD (1992) Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 77:29-36
21. Ratilal B, Costa J, Sampaio C (2008) Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a systematic review. J Neurosurg Pediatrics 1:48-56 (Pubitemid 351396993)
22. Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE (2007) Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 8(7):38
23. Richards HK, Seeley HM, Pickard JD (2009) Efficacy of antibiotic-impregnated shunt catheters in reducing shunt infection: data from the United Kingdom Shunt Registry. J Neurosurg Pediatr 4(4):389-393
24. Ronan A, Hogg GG, Klug GL (1995) Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 14:782-786
25. Schiff SJ, Oakes WJ (1989) Delayed cerebrospinal-fluid shunt infection in children. Pediatr Neurosci 15:131-135 (Pubitemid 20309531)
26. Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, Jallo GI (2005) Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 103:131-136 (Pubitemid 44954920)
27. Sciubba DM, Lin LM, Woodworth GF, McGirt MJ, Carson B, Jallo GI (2007) Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus 22(4):E9
28. Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI (2007) Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 23:867-871 (Pubitemid 47029080)
29. Shapiro S, Boaz J, Kleiman M, Kalsbeck J, Mealey J (1988) Origin of organisms infecting ventricular shunts. Neurosurgery 22:868-872
30. Taggart DP, D'Amico R, Altman DG (2001) Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet 358(9285):870-875 (Pubitemid 32900568)
31. Thompson DN, Hartley JC, Hayward RD (2007) Shunt infection: is there a near-miss scenario? J Neurosurg 106(1 Suppl):15-19
32. Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP (1984) Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 60:1014-1021 (Pubitemid 14134808)
33. Wang KW, Chang WN, Shih TY, Huang CR, Tsai NW, Chang CS, Chuang YC, Liliang PC, Su TM, Rau CS, Tsai YD, Cheng BC, Hung PL, Chang CJ, Lu CH (2004) Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes. Jpn J Infect Dis 57:44-48